Meridian Express Limited
⚠️ High Risk
FEI: 3009491090 • Accra • GHANA
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
DIETARYLBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/18/2012 | 54ABY05VITAMIN B12 (CYANOCOBALAMIN) | Minneapolis District Office (MIN-DO) | |
| 5/18/2012 | 03AGY12WHITE BREAD/ROLLS/BUNS | 249FILTHY | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
| 5/18/2012 | 60LAA01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Minneapolis District Office (MIN-DO) |
Frequently Asked Questions
What is Meridian Express Limited's FDA import refusal history?
Meridian Express Limited (FEI: 3009491090) has 9 FDA import refusal record(s) in our database, spanning from 5/18/2012 to 5/18/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Meridian Express Limited's FEI number is 3009491090.
What types of violations has Meridian Express Limited received?
Meridian Express Limited has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Meridian Express Limited come from?
All FDA import refusal data for Meridian Express Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.